CG Oncology CGON Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$186.75M-16.0% | -$161M-6.3% | -$151.48M-18.3% | -$128.08M-21.3% | -$105.56M-19.9% | ||
| $2.26M+56.5% | $1.45M+142% | $596K+197% | $201K+287% | $52K+62.5% | ||
| $28M+5.0% | $26.68M+9.0% | $24.48M+23.7% | $19.8M+31.7% | $15.04M+31.9% | ||
| -$160.01M-20.9% | -$132.35M-13.3% | -$116.79M-24.5% | -$93.82M-14.4% | -$81.98M-4.1% | ||
| $422K+215% | $134K-60.1% | $336K+40.6% | $239K0.0% | $239K+1.7% | ||
| —— | —— | —— | —— | —— | ||
| $546.43M+255% | $153.89M-44.7% | $278.23M+23.1% | $226.03M0.0% | $226.07M-64.0% | ||
| —— | —— | —— | -$10.53M— | —— | ||
| -$160.43M-21.1% | -$132.48M-13.1% | -$117.13M-24.5% | -$94.06M-14.4% | -$82.22M-4.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does CG Oncology's cash flow data come from?
- Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.